25 results
Thumbnail

D2.90 - Potato Allergy in Children: Clinical Features, Laboratory Findings, and Tolerance Development

Thumbnail

D2.91 - Exploring Geographic Differences in Ragweed and Mugwort Hypersensitivity Among Patients with Respiratory Symptoms of Allergy in Eastern and Western Europe

Thumbnail

D2.100 - Carcinoid Crisis Mimicking IgE-Mediated Hypersensitivity Reaction During Peptide Receptor Radionuclide Therapy (PRRT): A Diagnostic Dilemma

Thumbnail

D2.102 - Hidden metal triggers in allergic contact dermatitis

Thumbnail

D2.103 - Severe Persistent Allergic Rhinitis in an Adolescent: A SNOT-22–Based Case Report

Thumbnail

D2.104 - Mental Health Care and Support in Patients with Atopic Dermatitis in Kazakhstan: One-Year Follow-Up Study

Thumbnail

D2.92 - LTP-Mediated Corn-Induced Anaphylaxis

Thumbnail

D2.93 - The role of tropomyosins in allergenic cross-reactivity

Thumbnail

D2.94 - Anaphylaxis to human serum albumin in a patient with liver cirrhosis – a diagnostic challenge

Thumbnail

D2.95 - Comparative Molecular IgE Sensitization Patterns Across Developmental Stages: A Cross-Sectional Study in Clinical Cohorts from Ankara and Tehran

Thumbnail

D2.96 - Perioperative Anaphylaxis in Sri Lanka: Evaluation in a Low-Resource Setting

Thumbnail

D2.97 - Overall Prevalence and Particular Importance of Studying Sensitization to Peanut Molecules

Thumbnail

D2.98 - Allergic Contact Dermatitis from 2-Hydroxyethyl Methacrylate in a Nail Technician

Thumbnail

D2.99 - The mysterious cases of anaphylaxis to döner kebab in Germany/Switzerland with subsequent tolerance in Türkiye: an unwelcome guest causes trouble

Thumbnail

D3.418 - A Phase 1b Study of Lesigercept, a Long-acting High-affinity IgETrap-Fc Fusion Protein: Safety, Tolerability, PK, and PD in Atopic Healthy and Allergic Subjects

Thumbnail

D3.419 - Efficacy, safety, and remission outcomes of omalizumab in elderly patients with severe allergic asthma: a subgroup analysis by age of onset

Thumbnail

D3.420 - Real-world epidemiologic characteristics of patients treated with dupilumab for type 2 inflammatory indications: a single-center retrospective cohort study

Thumbnail

D3.421 - Real-world Effectiveness and Safety of Lanadelumab Treatment in Patients With Hereditary Angioedema: The 12-Month Interim Analysis of a Polish, Prospective, Multicenter, Observational Study (CHOPIN)

Thumbnail

D3.422 - Dupilumab in children with multimorbid atopic phenotype: therapy efficacy, safety and biomarker changes

Thumbnail

D3.423 - Lanadelumab treatment is effective and safe in patients with Factor XII associated cold-induced autoinflammatory syndrome: results from an open-label proof-of-concept study